Mechanism of HMGB1 release inhibition from RAW264.7 cells by oleanolic acid in Prunus mume Sieb. et Zucc

International Journal of Molecular Medicine

Volumn 23, Issue 5, 2009, Pages 615-620

  Kawahara, Ko Ichi ^a   Hashiguchi, Teruto ^a   Masuda, Kazuo ^b   Saniabadi, Abbi R ^c   Kikuchi, Kiyoshi ^a   Tancharoen, Salunya ^d   Ito, Takashi ^a   Miura, Naoki ^e   Morimoto, Yoko ^a   Biswas, Kamal K ^a   Nawa, Yuko ^a   Meng, Xiaojie ^a   Oyama, Yoko ^a   Takenouchi, Kazunori ^a   Shrestha, Binita ^a   Sameshima, Hisayo ^a   Shimizu, Toshiaki ^a   Adachi, Taro ^f   Adachi, Masakazu ^f   Maruyama, Ikuro ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Showa Pharmaceutical University   (Japan)

^c JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^d MAHIDOL UNIVERSITY   (Thailand)

^e KAGOSHIMA UNIVERSITY   (Japan)

^f Ada Bio Co Ltd   (Japan)

Author keywords

Heme oxygenase 1; High mobility group box 1; Nrf2; Oleanolic acid; Ume extract

Indexed keywords

HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; LIPOPOLYSACCHARIDE; OLEANOLIC ACID; PRUNUS EXTRACT; PRUNUS MUME EXTRACT; TRANSCRIPTION FACTOR NRF2; TRITERPENOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PRUNUS; PRUNUS MUME; TRANSCRIPTION INITIATION;

EID: 67649429266     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000172     Document Type: Article

References (41)

1. Lu J, Kobayashi R and Brill SJ: Characterization of a high mobility group 1/2 homolog in yeast. J Biol Chem 271: 33678-33685, 1996.
2. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251, 1999.
3. Taniguchi N, Kawahara K, Yone K, et al: High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 48: 971-981, 2003.
4. Kawahara K, Kamal KB, Unoshima M, et al: CRP induces high mobility group box-1 protein release through a p38MAPK in the macrophage cell line RAW264.7 cells. Cardiovasc Pathol 17: 129-138, 2008.
5. Park JS, Svetkauskaite D, He Q, et al: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279: 7370-7377, 2004.
6. Ito T, Kawahara K, Nakamura T, et al: High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost 5: 109-116, 2007.
7. Ito T, Kawahara KI, Okamoto K, et al: Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes. Arterioscler Thromb Vasc Biol 28: 1825-1830, 2008.
8. Morimoto Y, Kawahara K, Tancharoen S, et al: Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1. J Periodontal Res 43: 76-83, 2008.
9. Kawahara K, Setoyama K, Kikuchi K, et al: HMGB1 release in co-cultures of porcine endothelial and human T cells. Xenotransplantation 14: 636-641, 2007.
10. Porto A, Palumbo R, Pieroni M, et al: Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 20: 2565-2566, 2006.
11. Inoue K, Kawahara K, Biswas KK, et al: HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques. Cardiovasc Pathol 16: 136-143, 2007.
12. Kokkola R, Li J, Sundberg E, et al: Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum 48: 2052-2058, 2003.
13. Ulloa L, Ochani M, Yang H, et al: Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99: 12351-12356, 2002.
14. Wang H, Liao H, Ochani M, et al: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 11: 1216-1221, 2004.
15. Killeen ME, Englert JA, Stolz DB, et al: The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J Pharmacol Exp Ther 316: 1070-1079, 2006.
16. Jiang W, Bell CW and Pisetsky DS: The relationship between apoptosis and high-mobility group protein 1 release from murine macrophages stimulated with lipopolysaccharide or polyinosinic-polycytidylic acid. J Immunol 178: 6495-6503, 2007.
17. Tang D, Kang R, Xiao W, et al: Nuclear heat shock protein 72 as a negative regulator of oxidative stress (hydrogen peroxide)-induced HMGB1 cytoplasmic translocation and release. J Immunol 178: 7376-7384, 2007.
18. Chorny A and Delgado M: Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1. Am J Pathol 172: 1297-1307, 2008.
19. Chorny A, Anderson P, Gonzalez-Rey E and Delgado M: Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria. J Immunol 180: 8369-8377, 2008.
20. Hagiwara S, Iwasaka H, Matsumoto S and Noguchi T: High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med 34: 361-367, 2008.
21. Hagiwara S, Iwasaka H, Hidaka S, Hishiyama S and Noguchi T: Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats. Crit Care 12: R43, 2008.
22. Hagiwara S, Iwasaka H, Hasegawa A, Koga H and Noguchi T: Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Crit Care Med 36: 2407-2413, 2008.
23. Li W, Ashok M, Li J, Yang H, Sama AE and Wang H: A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS ONE 11: e1153, 2007.
24. Kawahara K, Tancharoen S, Hashiguchi T, et al: Inhibition of HMGB1 by deep ocean water attenuates endotoxin-induced sepsis. Med Hypotheses 68: 1429-1430, 2007.
25. Adachi M, Suzuki Y, Mizuta T, et al: The Japanese apricot Prunus mume Sieb. et Zucc (ume) is a rich natural source of novel anti-cancer substance. Int J Food Prop 10: 375-384, 2007.
26. Nakagawa A, Sawada T, Okada T, Ohsawa T, Adachi M and Kubota K: New antineoplastic agent, MK615, from UME (a variety of) Japanese apricot inhibits growth of breast cancer cells in vitro. Breast J 13: 44-49, 2007.
27. Mori S, Sawada T, Okada T, Ohsawa T, Adachi M and Keiichi K: New anti-proliferative agent, MK615, from Japanese apricot 'Prunus mume' induces striking autophagy in colon cancer cells in vitro. World J Gastroenterol 13: 6512-6517, 2007.
28. Okada T, Sawada T, Osawa T, Adachi M and Kubota K: MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World J Gastroenterol 14: 1378-1382, 2008.
29. Chung SW, Liu X, Macias AA, Baron RM and Perrella MA: Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest 118: 239-247, 2008.
30. Wiesel P, Patel AP, DiFonzo N, et al: Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102: 3015-3022, 2000.
31. Thimmulappa RK, Lee H, Rangasamy T, et al: Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116: 984-995, 2006.
32. Liby KT, Yore MM and Sporn MB: Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat Rev Cancer 5: 357-369, 2007.
33. Biswas KK, Sarker KP, Abeyama K, et al: Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. Hepatology 38: 1167-1177, 2003.
34. Cízková D, Rosocha J, Vanick I, Radonák J, Gálik J and Cízek M: Induction of mesenchymal stem cells leads to HSP72 synthesis and higher resistance to oxidative stress. Neurochem Res 31: 1011-1020, 2006.
35. Monge M, Ledemé N and Mazouz H: Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. Nephrol Dial Transplant 22: 1979-1985, 2007.
36. Tunçel N, Erden S, Uzuner K, Altiokka G and Tunçel M: Ischemic-reperfused rat skeletal muscle: the effect of vasoactive intestinal peptide (VIP) on contractile force, oxygenation and antioxidant enzyme systems. Peptides 18: 269-275, 1997.
37. El Eter E, Al Tuwaijiri A, Hagar H and Arafa M: In vivo and in vitro antioxidant activity of ghrelin: attenuation of gastric ischemic injury in the rat. J Gastroenterol Hepatol 22: 1791-1799, 2007.
38. Lim SC, Choi JE, Kim CH, et al: Ethyl pyruvate induces necrosis-to-apoptosis switch and inhibits high mobility group box protein 1 release in A549 lung adenocarcinoma cells. Int J Mol Med 20: 187-192, 2007.
39. Barichello T, Machado RA, Constantino L, et al: Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med 35: 2186-2190, 2007.
40. Otterbein L, Sylvester SL and Choi AMK: Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol 13: 595-601, 1995.
41. Kwak MH, Itoh K, Yamamoto M, et al: Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol Med 7: 135-145, 2001.